UpdatesPress Release
Cipla's US subsidiary partners with Qilu for exclusive licensing & supply of a Keytruda biosimilar (QL2107) in the US market.
Cipla LimitedCIPLA · Filed with the exchange
This strategic move aims to expand Cipla's oncology portfolio and improve access to affordable biologics.
No comments yet. Be the first.